SUPPLEMENTAL INDENTURE TO BE DELIVERED BY SUBSEQUENT GUARANTORSSupplemental Indenture • July 22nd, 2024 • Iqvia Holdings Inc. • Services-commercial physical & biological research • New York
Supplemental Indenture (this “Supplemental Indenture”), dated as of June 27, 2024, among Rules-Based Medicine Inc., a Delaware corporation, Lasso Marketing, Inc., a Delaware corporation and Cognitive Clinical Trials, LLC, a Delaware limited liability company (each a “Guaranteeing Subsidiary”), a subsidiary of IQVIA Inc., a Delaware corporation (the “Company”), and U.S. Bank Trust Company, National Association, as trustee (the “Trustee”) and as collateral agent (the “Collateral Agent”).
